Patents Represented by Attorney Bret Bozicevic & Reed Field
  • Patent number: 5734018
    Abstract: A method to obtain selected individual peptides or families thereof which have a target property and optionally to determine the amino acid sequence of a selected peptide or peptides to permit synthesis in practical quantities is disclosed. In general outline, the method of the invention comprises synthesizing a mixture of randomly or deliberately generated peptides using standard synthesis techniques, but adjusting the individual concentrations of the components of a mixture of sequentially added amino acids according to the coupling constants for each amino acid/amino acid coupling. The subgroup of peptides having the target property can then be selected, and either each peptide isolated and sequenced, or analysis performed on the mixture to permit its composition to be reproduced. Also included in the invention is an efficient method to determine the relevant coupling constants.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: March 31, 1998
    Assignee: The Regents of the University of California
    Inventors: William J. Rutter, Daniel V. Santi
  • Patent number: 5695752
    Abstract: Compositions are administered to a patient (preferably by injection and locally) to treat a variety of conditions including inflammation associated with trauma and with certain aspects of diseases such as rheumatoid arthritis, psoriasis, insulin-dependent diabetes, cutaneous lymphomas, duodenal ulcer, chronic proctitis, lymphocytic thyroidiris, hemorphagic shock, reperfusion injury during transplantation and multiple sclerosis. The compositions are pharmaceutically acceptable injectable formulations which include an active component in a pharmaceutically acceptable carrier. The active component is a chlorate or selenate which inhibits the natural biochemical sulfation process and/or a sulfatase enzyme which removes a sulfate from a specific position of a saccharide molecule which makes up a part of a natural ligand for L-selectin. Removal of the sulfate from the ligand hinders the ability of the ligand to bind to its natural receptor (i.e.
    Type: Grant
    Filed: June 30, 1995
    Date of Patent: December 9, 1997
    Assignee: The Regents of the University of California
    Inventors: Steven D. Rosen, Stefan Hemmerich, Yasuyuki Imai
  • Patent number: 5688246
    Abstract: A microcannula suitable for cannulation of very small blood vessels in a small animal, neonate or adult having a sharp pointed trochar tightly but removable placed in the lumen of the microcannula. The trochar is held in place by contact friction from an area of reduced inside diameter distal to the tip end, formed by welding the end distal of the microcannula to a tube having a slightly larger diameter. A process for making a microcannula.
    Type: Grant
    Filed: October 24, 1995
    Date of Patent: November 18, 1997
    Assignee: BioTime, Inc.
    Inventors: Harold D. Waitz, Hal Sternberg, Paul E. Segall, Bruce Cohen